Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. Reply
Related Posts
Tai JW, Shah VD, Harmon RL, Chandna S, Yan J, Fathizadeh P, Beaven S, Karunasiri D, Kim P. Vanishing Bile Duct Syndrome as a Rare[...]
Bejjani AC, Roayaie S, Finn RS. Targeting TIGIT to improve outcomes in advanced HCC. JHEP Rep. 2025 Oct 9;7(11):101552. doi: 10.1016/j.jhepr.2025.101552. PMID: 41635625; PMCID: PMC12861928.
Zeidner JF, Jain J, Welkie RL, Huang Y, Swords R, Traer E, Stein EM, Lin TL, Madanat YF, Collins RH Jr, Baer MR, Duong VH,[...]